Aequus Pharmaceuticals Correlations
| AQSZF Stock | USD 0.01 0.0005 7.04% |
The current 90-days correlation between Aequus Pharmaceuticals and Dyadic International is 0.21 (i.e., Modest diversification). The correlation of Aequus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Aequus Pharmaceuticals Correlation With Market
Average diversification
The correlation between Aequus Pharmaceuticals and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Aequus Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Aequus |
The ability to find closely correlated positions to Aequus Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aequus Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aequus Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aequus Pharmaceuticals to buy it.
Moving together with Aequus OTC Stock
| 0.74 | EC | Ecopetrol SA ADR | PairCorr |
| 0.63 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.74 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.79 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.74 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
Moving against Aequus OTC Stock
| 0.89 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.89 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.84 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.82 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.8 | HPQ | HP Inc | PairCorr |
| 0.78 | WMT | Walmart Aggressive Push | PairCorr |
| 0.75 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.71 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
| 0.63 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.62 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.53 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.52 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.49 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.42 | KB | KB Financial Group | PairCorr |
| 0.41 | VFS | VinFast Auto Earnings Call This Week | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Aequus OTC Stock performing well and Aequus Pharmaceuticals OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Aequus Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RZLT | 2.87 | 0.11 | 0.05 | 0.19 | 3.11 | 6.81 | 30.01 | |||
| TPST | 3.89 | (0.73) | 0.00 | (0.52) | 0.00 | 6.38 | 29.55 | |||
| FBRX | 5.65 | 1.63 | 0.41 | 1.11 | 3.42 | 6.65 | 113.07 | |||
| DYAI | 3.76 | 0.55 | 0.13 | 0.86 | 3.69 | 9.00 | 16.89 | |||
| DMAC | 2.31 | 0.28 | 0.07 | 4.62 | 2.11 | 4.94 | 10.25 | |||
| SILO | 3.77 | (0.54) | 0.00 | 206.49 | 0.00 | 6.31 | 23.28 | |||
| MOLN | 4.66 | (0.26) | 0.00 | (0.11) | 0.00 | 9.61 | 52.92 | |||
| MLYS | 2.68 | (0.08) | 0.03 | 0.09 | 3.37 | 6.27 | 20.98 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aequus Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |